Equibles does not estimate personal net worth.
Get an email with a short summary when Clover Health Investments, Corp. publishes a filing, an earnings call transcript or a press release.
Get CLOV alertsAndrew Toy is recorded as CTO, Board Member and CEO at Clover Health Investments, Corp. (CLOV). The newest filing on record that lists Andrew Toy as Board Member and CEO at Clover Health Investments, Corp. (CLOV) is dated April 28, 2026. Clover Health Investments, Corp. reported in an 8-K filed August 10, 2022 that Andrew Toy was appointed Co-Founder and CEO, effective January 1, 2023. The proxy statement of Clover Health Investments, Corp. reports total compensation of $1,319,385 for Andrew Toy in fiscal 2025, including a base salary of $800,000. Disclosed compensation is on record for 7 fiscal years. Andrew Toy has spoken on 18 earnings calls across 1 company, most recently for Clover Health Investments, Corp. on August 5, 2026. Clover Health Investments, Corp. is classified in the Healthcare Plans industry within the Healthcare sector. Other leadership on record at Clover Health Investments, Corp. includes Conrad Wai (CEO and CTO), Jamie L. Reynoso (CEO and COO), Vivek Garipalli (Chairman and Board Member) and 7 others.
“Andrew Toy, the Company's current President, will be promoted to the position of Co-Founder and CEO and will no longer serve as President.”
“At Clover, we've always believed the greatest opportunity for AI in healthcare is not simply to make the existing system a little more efficient. It's to help physicians make better decisions for individual patients at the point of care.”
“Entering 2026, our first quarter results demonstrate how market-leading growth, GAAP net income profitability and full risk can scale together in Medicare Advantage.”
“Our Medicare Advantage plan allows us to rapidly iterate our technology in real-world clinical settings, and Counterpart enables us to scale those capabilities across the entire healthcare ecosystem.”
“There are three main areas I want to focus on today. Firstly, that our growth engine is running well, and we remain focused on growing sustainably and profitably.”
“We are happy to report that we delivered yet another impactful quarter this year, building our momentum and demonstrating our ability to achieve meaningful growth alongside sustained adjusted EBITDA profitability in Medicare Advantage through the first half of the year.”
Start not stated–present
Last confirmed April 28, 2026
Start not stated–present
Last confirmed April 28, 2026
Healthcare Plans · Healthcare
CTO, Board Member, CEO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Clover Health Investments, Corp. (CLOV) | Co-Founder and Chief Executive Officer | $800,000 | $1,319,385 |
| 2024 | Clover Health Investments, Corp. (CLOV) | Co-Founder and Chief Executive Officer | $721,311 | $9,476,723 |
| 2023 | Clover Health Investments, Corp. (CLOV) | Co-Founder and Chief Executive Officer | $700,000 | $10,154,701 |
| 2022 | Clover Health Investments, Corp. (CLOV) | Co-Founder and Chief Executive Officer | $500,000 | $10,171,476 |
| 2021 | Clover Health Investments, Corp. (CLOV) | Co-Founder and Chief Executive Officer | $450,000 | $141,987,507 |
| 2020 | Clover Health Investments, Corp. (CLOV) | President | $415,385 | $8,617,885 |
| 2019 | Clover Health Investments, Corp. (CLOV) | President | $400,000 | $423,593 |
